Dr. Andrew Day is an Assistant Professor of Otolaryngology – Head and Neck Surgery at the University of Texas Southwestern Medical Center (UTSW) and a Eugene P. Frenkel, M.D. Scholar in Clinical Medicine.  He is also an Associate Member of the Harold C. Simmons Comprehensive Cancer Center’s (HCSCCC’s) Population Science and Cancer Control Program.  He is a member of the National Comprehensive Cancer Network (NCCN) Survivorship Panel and the NRG Head and Neck Surgical Subcommittee.  He is also co-director of the National Cancer Institute’s Cancer Center (Tobacco) Cessation Initiative (C3I) at the HCSCCC.

Dr. Day’s primary research emphases are in head and neck cancer prevention and control.  Specifically, he is evaluating gaps in head and neck cancer survivorship care and the secondary prevention of human papillomavirus (HPV)-mediated oropharyngeal cancer (OPC).  He has led two prospective, intramural observational cohort pilot studies in these domains.  He is currently co-principal investigator for a multicenter, investigator-initiated study evaluating a screening program for HPV-associated cancers in middle-aged men.  His secondary research interests include head and neck cancer outcomes, with emphases in HPV+ OPC and cutaneous squamous cell carcinoma.